Alptraumstörungen: Hilfe durch Imagery Rescripting und Imaginal Exposure

2021 ◽  
Vol 22 (03) ◽  
pp. 8-8

Alpträume können als Symptom einer posttraumatischen Belastungsstörung (PTBS), aber auch idiopathisch ohne traumatische Auslöser auftreten. Derzeit gibt es unterschiedliche Ansätze, um chronische Alptraumstörungen zu behandeln – in der Vergangenheit erwiesen sich sowohl das Imagery Rescritping (IR) als auch das Imaginal Exposure (IE) als wirksam. Bislang gibt es jedoch keine Studie, die beide Ansätze bezüglich ihrer Wirksamkeit vergleicht.

2021 ◽  
pp. 1-13
Author(s):  
Carolin Schmid ◽  
Kathrin Hansen ◽  
Tana Kröner-Borowik ◽  
Regina Steil

<b><i>Introduction:</i></b> Both imagery rescripting and imaginal exposure have been proven to be effective in the treatment of chronic nightmares when compared to a waitlist condition. Little is known about their comparative efficacy and their efficacy compared to an active control. <b><i>Objective:</i></b> The aims of this study were to compare the two treatments to one another and to positive imagery as an active control, and to explore covariates of the treatment effect. <b><i>Methods:</i></b> In this single-blinded randomized controlled trial, 96 patients with nightmare disorder (idiopathic nightmares) from an outpatient clinic were randomly assigned to a single individual treatment session of rescripting, exposure, or positive imagery and 4 weeks of practice at home. The primary outcome was nightmare distress, and the secondary outcomes were nightmare frequency, nightmare effects, self-efficacy, and general psychopathology. <b><i>Results:</i></b> Nightmare distress was reduced in all groups (imagery rescripting: Cohen’s <i>d</i> = –1.04, imaginal exposure: <i>d</i> = –0.68, positive imagery: <i>d</i> = –0.57), as were nightmare frequency, nightmare effects, and psychopathology. Self-efficacy was enhanced. No differential treatment effects were found on any primary or secondary measure. Treatment gains were not associated with demographic or disorder characteristics, baseline values, treatment credibility, or the number of practice sessions. <b><i>Conclusions:</i></b> Even short nightmare treatments are effective regardless of personal characteristics, and different interventions produce similar results. Future research should aim to clarify the mechanisms of action. Health care should make more use of these powerful and easy-to-administer nightmare treatments.


2019 ◽  
Vol 50 (5) ◽  
pp. 978-993 ◽  
Author(s):  
Anna E. Kunze ◽  
Jaap Lancee ◽  
Nexhmedin Morina ◽  
Merel Kindt ◽  
Arnoud Arntz

2019 ◽  
Vol 10 (2) ◽  
pp. 204380871985073 ◽  
Author(s):  
Anna E. Kunze ◽  
Arnoud Arntz ◽  
Merel Kindt

Imagery rescripting (IR) is a promising treatment for a variety of disorders, but its working mechanisms remain largely unknown. To elucidate the associative and evaluative learning processes underlying IR, we exposed participants to an aversive film clip followed by an instructed fear-conditioning procedure. The acquired fear memory was subsequently manipulated by either rescripting- (IR) or exposure-based (imaginal exposure; IE) interventions and their effects were examined on subjective and psychophysiological fear responses in three successive studies. Though the interpretation of the results was challenged with respect to the employed analogue IR intervention (Exp 1) and unexpected findings in the control condition (Exp 3), the present results establish preliminary evidence for the hypothesis that IR produces differential effects on fear responding when compared to IE. For example, in line with stimulus devaluation theory, IR effectively reduced subjective distress to the conditioned stimulus (Exp 2). Also, IR resulted in decreased physiological fear responses after fear reinstatement (Exp 3). The findings advance our general understanding of the processes involved in IR and they tentatively indicate that rescripting- and exposure-based treatments may work through different mechanisms. Moreover, this line of research demonstrates the challenges encountered when working with analogue models to test mechanisms of therapeutic change.


2017 ◽  
Vol 97 ◽  
pp. 14-25 ◽  
Author(s):  
Anna E. Kunze ◽  
Arnoud Arntz ◽  
Nexhmedin Morina ◽  
Merel Kindt ◽  
Jaap Lancee

1999 ◽  
Author(s):  
N. Tarrier ◽  
H. Pilgram ◽  
C. Sommerfield ◽  
B. Faragher ◽  
M. Reynolds ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document